The FDA and CDC have recommended a halt in the use of the J&J vaccine after a half dozen cases of blood clots among women.
According to FDA, the CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance.
The following is a statement by the FDA:
"Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution," the CDC and FDA wrote in a joint statement.
"This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot."